Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

and olmesartan medoxomil + HCTZ + amlodipine, are presented in Figure 4. Patients who were treated for 8 weeks with olmesartan medoxomil alone (n=198) had a mean reduction in SeDBP from 96.6 mm Hg ...